Categories Uncategorized

Research Shows That Healthy Sleep Patterns Decrease Heart Failure Risk

According to new research that was reported in “Circulation,” the American Heart Association journal, adults who had healthy sleeping patterns had a lower risk of heart failure. This was in comparison to grown-ups who had unhealthy sleep patterns.

Healthy sleeping patterns are characterized by waking up in the morning, sleeping seven to eight hours every day and having no excessive daytime sleepiness, snoring or frequent insomnia. Emerging evidence shows that sleep problems may have a hand in heart failure development. Heart failure affects over 26 million individuals globally.

The observational study looked into the relationship between heart failure and healthy sleep patterns. It included the data on 408,802 Biobank participants from the UK, who were aged between 37 and 73 at the time of recruitment, which was between 2006 and 2010. The prevalence of heart failure was collected until April 1, 2019. Researchers documented 5,221 heart failure cases during a follow up of 10 years.

Researchers examined overall sleep patterns and sleep quality. Measures of sleep quality included snoring, insomnia, sleep duration and other features related to sleep, such as whether a participant had any daytime sleepiness or if they were a night owl or an early bird.  The professor of epidemiology and the corresponding author of the study, Lu Qi, stated that the team had developed a healthy sleep score based off of the scoring of these five sleep behaviors.

Qi, who is also the director at Tulane University’s Obesity Research Center in New Orleans, added that the study results emphasized the importance of improving overall sleep patterns as a way to prevent heart failure.

In the study, sleep duration was defined in three categories: 9 hours or more daily (prolonged), seven to eight hours daily(recommended) and less than seven hours daily (short). After the researchers adjusted for genetic variations, medication use, hypertension, diabetes and other covariates, they discovered that the participants with very healthy sleep patterns had a 42% lower risk of heart failure as compared to those who had unhealthy sleep patterns.

They also discovered that the risk of heart failure was independently linked and was 34% lesser in participants who reported no daytime sleepiness, 17% lesser in participants who didn’t have frequent insomnia, 12% lesser in individuals who slept for the recommended time frame and 8% lesser in participants who were early risers.

Sleep behaviors by the participants were self-reported with researchers noting that other unknown or unmeasured adjustments may have influenced the study’s findings.

Lots of companies are investing heavily in helping people to adjust their behaviors so that serious or chronic health conditions can be managed effectively. One of those firms is DarioHealth Corp. (NASDAQ: DRIO). The company provides smartphone-based, chronic, disease-management software to make it possible for better disease management.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Currently Approved Drug Could Boost Immunotherapy Against Liver Cancer

Researchers at University of Washington have discovered that a drug that is currently approved by…

20 hours ago

HeartBeam Inc. (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital

Advances in digital health, cloud computing and data analytics are making it possible to move…

20 hours ago

Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Manufacturing and Development Efforts as It Pursues a Novel Approach to Hard-to-Treat Cancers

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. Onco-Innovations is advancing a…

21 hours ago

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks

Cardio Diagnostics has positioned the science of epigenetics at the center of its diagnostic platform.…

2 days ago

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease (‘CHD’) Detection

For decades, cardiovascular risk assessment has centered on a checklist of factors never designed to…

5 days ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Before…

5 days ago